Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MOVE - Mobilization and Outcomes After VEnous Closure - A Prospective Registry of Real-World Outcomes/Usage/Evidence for the MYNX CONTROL™ VENOUS Vascular Closure Device 6F-12F

NCT07246902 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.

NCT NCT07246902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07246902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MOVE - Mobilization and Outcomes After VEnous Closure - A Prospective Registry of Real-World Outcomes/Usage/Evidence for the MYNX CONTROL™ VENOUS Vascular Closure Device 6F-12F
Lead sponsor
Cordis US Corp.
Phase
Observational
Overall status
Completed
Start date
November 24, 2025
Completion date
August 26, 2026
Enrollment
339 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

electrophysiology study, venous vascular closure